Select Committee written evidence reported in the House of Commons on Monday, 11 January 2021 from the Committee of Public Accounts.
Correspondence from the Department for Business, Energy and Industrial Strategy and the Department of Health and Social Care relating to COVID-19 indemnities
Secondary information
- Type
- Parliamentary committee
- Session
- 2019-21
- Related items
-
Human Medicines (Coronavirus and Influenza) (Amendment) Regulations
Friday, 16 October 2020
Statutory instruments
House of Lords
House of Commons
- Subjects
- Devolution Correspondence Liability Procurement Vaccination Medicines and Healthcare products Regulatory Agency AstraZeneca Department for Business, Energy and Industrial Strategy Department of Health and Social Care Coronavirus
- Legislation
- Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020
- Link
- View this Parliamentary committee on committees.parliament.uk
Librarians' tools
- Timestamp
- 2024-11-28 10:31:43 +0000
- URI
- http://data.parliament.uk/selectcommittees/39831
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/selectcommittees/39831
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/selectcommittees/39831
- Internal location
- http://oasis.parliament.uk/OasisDocument/view/39831